The World Federation of Hemophilia's third global forum on the Safety and Supply of Hemophilia Treatment Products, 22-23 September 2003, Budapest, Hungary.

Suppr

超能文献

作者信息

Brooker M

出版信息

Haemophilia. 2004 May;10(3):290-4. doi: 10.1111/j.1365-2516.2004.00901.x.

DOI:10.1111/j.1365-2516.2004.00901.x

PMID:15086330

Abstract

摘要

相似文献

The World Federation of Hemophilia's third global forum on the Safety and Supply of Hemophilia Treatment Products, 22-23 September 2003, Budapest, Hungary.

Haemophilia. 2004 May;10(3):290-4. doi: 10.1111/j.1365-2516.2004.00901.x.

Cost trends in the treatment for hemophilia: another view.

Thromb Haemost. 2002 Oct;88(4):542-4.

Self-sufficiency--20 years on.

Blood Coagul Fibrinolysis. 1994 Dec;5 Suppl 4:S9-14.

Can costs of hemophilia products be curtailed? Not as we do business today!

Thromb Haemost. 2002 Oct;88(4):541.

Demographics of hemophilia in developing countries.

Semin Thromb Hemost. 2005 Nov;31(5):489-94. doi: 10.1055/s-2005-922218.

Hemophilia centre twinning with Nanfang Hospital, Guangzhou, China. Challenges and opportunities.

Transfus Apher Sci. 2001 Oct;25(2):83-7. doi: 10.1016/s1473-0502(01)00105-7.

Economic aspects of haemophilia care.

Haemophilia. 1999 May;5(3):216-9. doi: 10.1046/j.1365-2516.1999.00325.x.

High cost, low volume care: the case of haemophilia.

BMJ. 1997 Oct 18;315(7114):962-3. doi: 10.1136/bmj.315.7114.962.

GAO suggests Medicare make separate payments for clotting factors, delivery.

Am J Health Syst Pharm. 2003 Apr 15;60(8):741. doi: 10.1093/ajhp/60.8.741a.

Safety and supply of haemophilia products: worldwide perspectives.

Haemophilia. 2004 Jul;10(4):327-33. doi: 10.1111/j.1365-2516.2004.00910.x.

引用本文的文献

Endothelial progenitor cell-based therapy for hemophilia A.

Int J Hematol. 2012 Feb;95(2):119-24. doi: 10.1007/s12185-012-1015-z.

Blood safety and the choice of anti-hemophilic factor concentrate.

Pediatr Blood Cancer. 2006 Sep;47(3):245-54. doi: 10.1002/pbc.20895.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The World Federation of Hemophilia's third global forum on the Safety and Supply of Hemophilia Treatment Products, 22-23 September 2003, Budapest, Hungary.

Haemophilia. 2004 May;10(3):290-4. doi: 10.1111/j.1365-2516.2004.00901.x.

Cost trends in the treatment for hemophilia: another view.

Thromb Haemost. 2002 Oct;88(4):542-4.

Self-sufficiency--20 years on.

Blood Coagul Fibrinolysis. 1994 Dec;5 Suppl 4:S9-14.

Can costs of hemophilia products be curtailed? Not as we do business today!

Thromb Haemost. 2002 Oct;88(4):541.

Demographics of hemophilia in developing countries.

Semin Thromb Hemost. 2005 Nov;31(5):489-94. doi: 10.1055/s-2005-922218.

Hemophilia centre twinning with Nanfang Hospital, Guangzhou, China. Challenges and opportunities.

Transfus Apher Sci. 2001 Oct;25(2):83-7. doi: 10.1016/s1473-0502(01)00105-7.

Economic aspects of haemophilia care.

Haemophilia. 1999 May;5(3):216-9. doi: 10.1046/j.1365-2516.1999.00325.x.

High cost, low volume care: the case of haemophilia.

BMJ. 1997 Oct 18;315(7114):962-3. doi: 10.1136/bmj.315.7114.962.

GAO suggests Medicare make separate payments for clotting factors, delivery.

Am J Health Syst Pharm. 2003 Apr 15;60(8):741. doi: 10.1093/ajhp/60.8.741a.

Safety and supply of haemophilia products: worldwide perspectives.

Haemophilia. 2004 Jul;10(4):327-33. doi: 10.1111/j.1365-2516.2004.00910.x.

引用本文的文献

Endothelial progenitor cell-based therapy for hemophilia A.

Int J Hematol. 2012 Feb;95(2):119-24. doi: 10.1007/s12185-012-1015-z.

Blood safety and the choice of anti-hemophilic factor concentrate.

Pediatr Blood Cancer. 2006 Sep;47(3):245-54. doi: 10.1002/pbc.20895.